Literature DB >> 21913058

Prostate MRI: diffusion-weighted imaging at 1.5T correlates better with prostatectomy Gleason Grades than TRUS-guided biopsies in peripheral zone tumours.

Leonardo Kayat Bittencourt1, Jelle O Barentsz, Luiz Carlos Duarte de Miranda, Emerson Leandro Gasparetto.   

Abstract

OBJECTIVES: To investigate the usefulness of Apparent Diffusion Coefficients (ADC) in predicting prostatectomy Gleason Grades (pGG) and Scores (GS), compared with ultrasound-guided biopsy Gleason Grades (bGG).
METHODS: Twenty-four patients with biopsy-proven prostate cancer were included in the study. Diffusion-weighted images were obtained using 1.5-T MR with a pelvic phased-array coil. Median ADC values (b0,500,1000 s/mm²) were measured at the most suspicious areas in the peripheral zone. The relationship between ADC values and pGG or GS was assessed using Pearson's coefficient. The relationship between bGG and pGG or GS was also evaluated. Receiver operating characteristic (ROC) curve analysis was performed to assess the performance of each method on a qualitative level.
RESULTS: A significant negative correlation was found between mean ADCs of suspicious lesions and their pGG (r = -0.55; p < 0.01) and GS (r = -0.63; p < 0.01). No significant correlation was found between bGG and pGG (r = 0.042; p > 0.05) or GS (r = 0.048; p > 0.05). ROC analysis revealed a discriminatory performance of AUC = 0.82 for ADC and AUC = 0.46 for bGG in discerning low-grade from intermediate/high-grade lesions.
CONCLUSIONS: The ADC values of suspicious areas in the peripheral zone perform better than bGG in the correlation with prostate cancer aggressiveness, although with considerable intra-subject heterogeneity. KEY POINTS: • Prostate cancer aggressiveness is probably underestimated and undersampled by routine ultrasound-guided biopsies. • Diffusion-weighted MR images show good linear correlation with prostate cancer aggressiveness. • DWI information may be used to improve risk-assessment in prostate cancer.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21913058     DOI: 10.1007/s00330-011-2269-1

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  42 in total

1.  Usefulness of diffusion-weighted MRI with echo-planar technique in the evaluation of cellularity in gliomas.

Authors:  T Sugahara; Y Korogi; M Kochi; I Ikushima; Y Shigematu; T Hirai; T Okuda; L Liang; Y Ge; Y Komohara; Y Ushio; M Takahashi
Journal:  J Magn Reson Imaging       Date:  1999-01       Impact factor: 4.813

2.  Clinical utility of apparent diffusion coefficient (ADC) values in patients with prostate cancer: can ADC values contribute to assess the aggressiveness of prostate cancer?

Authors:  Yasushi Itou; Katsuyuki Nakanishi; Yoshifumi Narumi; Yasuko Nishizawa; Hideaki Tsukuma
Journal:  J Magn Reson Imaging       Date:  2011-01       Impact factor: 4.813

3.  Use of Gleason score, prostate specific antigen, seminal vesicle and margin status to predict biochemical failure after radical prostatectomy.

Authors:  M L Blute; E J Bergstralh; A Iocca; B Scherer; H Zincke
Journal:  J Urol       Date:  2001-01       Impact factor: 7.450

4.  The sextant protocol for ultrasound-guided core biopsies of the prostate underestimates the presence of cancer.

Authors:  M Norberg; L Egevad; L Holmberg; P Sparén; B J Norlén; C Busch
Journal:  Urology       Date:  1997-10       Impact factor: 2.649

5.  In vivo measurement of the apparent diffusion coefficient in normal and malignant prostatic tissues using echo-planar imaging.

Authors:  Bashar Issa
Journal:  J Magn Reson Imaging       Date:  2002-08       Impact factor: 4.813

6.  Magnetic resonance diffusion characteristics of histologically defined prostate cancer in humans.

Authors:  Junqian Xu; Peter A Humphrey; Adam S Kibel; Abraham Z Snyder; Vamsidhar R Narra; Joseph J H Ackerman; Sheng-Kwei Song
Journal:  Magn Reson Med       Date:  2009-04       Impact factor: 4.668

7.  Endorectal diffusion-weighted imaging in prostate cancer to differentiate malignant and benign peripheral zone tissue.

Authors:  Keyanoosh Hosseinzadeh; Samuel David Schwarz
Journal:  J Magn Reson Imaging       Date:  2004-10       Impact factor: 4.813

8.  Trends in Gleason score: concordance between biopsy and prostatectomy over 15 years.

Authors:  Ayyathurai Rajinikanth; Murugesan Manoharan; Cynthia T Soloway; Francisco J Civantos; Mark S Soloway
Journal:  Urology       Date:  2008-02-15       Impact factor: 2.649

9.  Cancer-specific mortality after surgery or radiation for patients with clinically localized prostate cancer managed during the prostate-specific antigen era.

Authors:  Anthony V D'Amico; Judd Moul; Peter R Carroll; Leon Sun; Deborah Lubeck; Ming-Hui Chen
Journal:  J Clin Oncol       Date:  2003-06-01       Impact factor: 44.544

10.  Diffusion-weighted magnetic resonance imaging: a potential non-invasive marker of tumour aggressiveness in localized prostate cancer.

Authors:  N M deSouza; S F Riches; N J Vanas; V A Morgan; S A Ashley; C Fisher; G S Payne; C Parker
Journal:  Clin Radiol       Date:  2008-04-18       Impact factor: 2.350

View more
  37 in total

1.  [Standardised scoring of a multi-parametric 3-T MRI for a targeted MRI-guided prostate biopsy].

Authors:  C Arsov; D Blondin; R Rabenalt; G Antoch; P Albers; M Quentin
Journal:  Urologe A       Date:  2012-06       Impact factor: 0.639

2.  Pilot Study of the Use of Hybrid Multidimensional T2-Weighted Imaging-DWI for the Diagnosis of Prostate Cancer and Evaluation of Gleason Score.

Authors:  Meredith Sadinski; Gregory Karczmar; Yahui Peng; Shiyang Wang; Yulei Jiang; Milica Medved; Ambereen Yousuf; Tatjana Antic; Aytekin Oto
Journal:  AJR Am J Roentgenol       Date:  2016-06-28       Impact factor: 3.959

3.  Assessment of Prostate Cancer Aggressiveness by Use of the Combination of Quantitative DWI and Dynamic Contrast-Enhanced MRI.

Authors:  Andreas M Hötker; Yousef Mazaheri; Ömer Aras; Junting Zheng; Chaya S Moskowitz; Tatsuo Gondo; Kazuhiro Matsumoto; Hedvig Hricak; Oguz Akin
Journal:  AJR Am J Roentgenol       Date:  2016-02-22       Impact factor: 3.959

4.  Apparent diffusion coefficient value is a strong predictor of unsuspected aggressiveness of prostate cancer before radical prostatectomy.

Authors:  Raphaele Renard Penna; Geraldine Cancel-Tassin; Eva Comperat; Pierre Mozer; Priscilla Léon; Justine Varinot; Morgan Roupret; Marc-Olivier Bitker; Olivier Lucidarme; Olivier Cussenot
Journal:  World J Urol       Date:  2016-02-22       Impact factor: 4.226

5.  Diagnosis of typical and atypical transition zone prostate cancer and its mimics at multiparametric prostate MRI.

Authors:  Jinxing Yu; Ann S Fulcher; Sarah G Winks; Mary A Turner; Ryan D Clayton; Michael Brooks; Sean Li
Journal:  Br J Radiol       Date:  2017-03-29       Impact factor: 3.039

6.  Development of a Combined MR Fingerprinting and Diffusion Examination for Prostate Cancer.

Authors:  Alice C Yu; Chaitra Badve; Lee E Ponsky; Shivani Pahwa; Sara Dastmalchian; Matthew Rogers; Yun Jiang; Seunghee Margevicius; Mark Schluchter; William Tabayoyong; Robert Abouassaly; Debra McGivney; Mark A Griswold; Vikas Gulani
Journal:  Radiology       Date:  2017-02-10       Impact factor: 11.105

7.  In vivo prostate cancer detection and grading using restriction spectrum imaging-MRI.

Authors:  K C McCammack; C J Kane; J K Parsons; N S White; N M Schenker-Ahmed; J M Kuperman; H Bartsch; R S Desikan; R A Rakow-Penner; D Adams; M A Liss; R F Mattrey; W G Bradley; D J A Margolis; S S Raman; A Shabaik; A M Dale; D S Karow
Journal:  Prostate Cancer Prostatic Dis       Date:  2016-01-12       Impact factor: 5.554

8.  Feasibility study of computed vs measured high b-value (1400 s/mm²) diffusion-weighted MR images of the prostate.

Authors:  Leonardo K Bittencourt; Ulrike I Attenberger; Daniel Lima; Ralph Strecker; Andre de Oliveira; Stefan O Schoenberg; Emerson L Gasparetto; Daniel Hausmann
Journal:  World J Radiol       Date:  2014-06-28

Review 9.  Focal ablation of prostate cancer: four roles for magnetic resonance imaging guidance.

Authors:  Graham Sommer; Donna Bouley; Harcharan Gill; Bruce Daniel; Kim Butts Pauly; Chris Diederich
Journal:  Can J Urol       Date:  2013-04       Impact factor: 1.344

10.  Diffusion-weighted MRI, 11C-choline PET and 18F-fluorodeoxyglucose PET for predicting the Gleason score in prostate carcinoma.

Authors:  Joe H Chang; Daryl Lim Joon; Sze Ting Lee; Chee-Yan Hiew; Stephen Esler; Sylvia J Gong; Morikatsu Wada; David Clouston; Richard O'Sullivan; Yin P Goh; Henri Tochon-Danguy; J Gordon Chan; Damien Bolton; Andrew M Scott; Vincent Khoo; Ian D Davis
Journal:  Eur Radiol       Date:  2013-11-06       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.